Regarding tumor‐infiltrating immune cells, a recent study that investigated the proportions of malignant and immune cells expressing PD‐L1 in patients with NSCLC showed poor concordance in the scoring of immune cells among pathologists 28. The gene discussed is CD274; the disease is neoplasm.